LONG-TERM OUTCOMES IN HEART TRANSPLANT RECIPIENTS WHO RECEIVED GANCICLOVIR PROPHYLAXIS: IMPACT OF CMV AND CMV SEROSTATUS ON REJECTION, ALLOGRAFT VASCULOPATHY, AND SURVIVAL.
2016 ◽
Vol 35
(6)
◽
pp. 752-759
◽
2015 ◽
Vol 65
(10)
◽
pp. A1710
2011 ◽
Vol 30
(4)
◽
pp. S197
2013 ◽
Vol 32
(4)
◽
pp. S52
Keyword(s):
2010 ◽
Vol 29
(2)
◽
pp. S23-S24
◽